- Bayer shares lower: investigation of the kidney drug finerenone in type 1 diabetes finanzen.ch
- Bayer shares lose: Kidney drug finerenone is also being studied in type 1 diabetes finanzen.net
- See more on the topic in Google News
Bayer shares lower: investigation of the kidney drug finerenone in type 1 diabetes – finanzen.ch
![](https://allnewspresscdn.cloudspecter.com/wp-content/uploads/2023/06/Bayer-shares-lower-investigation-of-the-kidney-drug-finerenone-in.jpg)